Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • Article
  • New England Journal of Medicine

Supporting Value-Based Health Care—Aligning Financial and Legal Accountability

By: Mark M. Zaki, Anupam B. Jena and Amitabh Chandra
  • Format:Print
ShareBar

Abstract

U.S. health care payment and delivery-system reforms have focused on improving care by making organizations accountable for outcomes, quality, and costs. Payers have supported the implementation of accountable care organizations (ACOs), bundled-payment models, and other value-based payment reforms because they believe that holding health care systems accountable for population-level costs and quality will be more effective than focusing accountability at the physician level. Evidence suggests that these models have increased value but have underperformed relative to the aspirations for them.

Keywords

Value-based Health Care; Accountability; Health Care and Treatment; United States

Citation

Zaki, Mark M., Anupam B. Jena, and Amitabh Chandra. "Supporting Value-Based Health Care—Aligning Financial and Legal Accountability." New England Journal of Medicine 385, no. 11 (September 9, 2021): 965–967.
  • Find it at Harvard
  • Register to Read

About The Author

Amitabh Chandra

Technology and Operations Management
→More Publications

More from the Authors

    • January 2023
    • Faculty Research

    Vertex and the Cure for Type 1 Diabetes

    By: Amitabh Chandra, William J Anderson and Silvia Mare
    • 2022
    • Faculty Research

    Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation

    By: Amitabh Chandra, Jennifer Kao, Kathleen Miller and Ariel D. Stern
    • July 2022
    • Faculty Research

    Gilead Sciences: Developing a Biopharmaceutical Pipeline Through M&A (Spreadsheet Supplement)

    By: Amitabh Chandra, Paul Clancy and Craig Garthwaite
More from the Authors
  • Vertex and the Cure for Type 1 Diabetes By: Amitabh Chandra, William J Anderson and Silvia Mare
  • Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation By: Amitabh Chandra, Jennifer Kao, Kathleen Miller and Ariel D. Stern
  • Gilead Sciences: Developing a Biopharmaceutical Pipeline Through M&A (Spreadsheet Supplement) By: Amitabh Chandra, Paul Clancy and Craig Garthwaite
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College